Vitamin D3 Supplementation for Heart Failure Patients
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with vitamin D3 of 10,000
International Units (IU) daily in vitamin D deficient patients for 6 months will improve B
type natriuretic peptide (BNP), a marker of heart function, compared to placebo. The
investigators also aim to determine if vitamin D helps cardiopulmonary function as evaluated
by cardiopulmonary exercise test (CPX), laboratory values, strength, and quality of life in
patients with stable congestive heart failure (Class II or III).
Phase:
Phase 2
Details
Lead Sponsor:
Heidi Moretti, MS, RD
Collaborator:
Saint Patrick Hospital
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins